Matthieu M.
- Country
- France
- Department
- Internal medicine
Research Overview
- HydroxyChloroquine as steroid-sparing Agent in Extra-pulmonary SARcoidosis. A multicenter, prospective, placebo-controlled, randomized trial. CAESAR
- Phase 2a Study of Tafasitamab in Adults with Primary Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia
- Evaluation of Intravenous Human Normal Immunoglobulin, Oral Prednisone, and High-Dose Dexamethasone in Adult Immune Thrombocytopenia with Bleeding
Data & Insights
Has run more than one trial at 31 of 70 partner sites.
Specializations
Autoimmune Disorders
This investigator specializes in treating immune thrombocytopenia (ITP), conducting research into various therapeutic approaches including combination treatments with rituximab and innovative immunomodulators.
- Treatment optimization for ITP patients
- Management of bleeding manifestations
- Immunoglobulin therapy applications
The research extends to comparing different therapeutic regimens involving corticosteroids and immunoglobulins for optimal patient outcomes.
Inflammatory Conditions
The investigator focuses on advancing treatment protocols for sarcoidosis, particularly exploring innovative approaches in both pulmonary and extra-pulmonary manifestations.
- Pulmonary sarcoidosis management
- Extra-pulmonary sarcoidosis treatment
- TNF-alpha antagonist therapy
Research includes evaluating steroid-sparing strategies and alternative therapeutic agents like hydroxychloroquine.
Therapeutic Innovation
The investigator explores immunomodulatory treatments and their applications in various immune system disorders, with particular attention to maintenance therapy strategies.
- Steroid-sparing approaches
- Combination therapy protocols
- Remission maintenance strategies
Research encompasses novel therapeutic combinations and comparative effectiveness studies of different treatment modalities.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.